Regulation of Human Mast Cell Function
人体肥大细胞功能的调节
基本信息
- 批准号:7072616
- 负责人:
- 金额:$ 12.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-08-01 至 2009-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The long-term goal is for Dr. Zhao to develop as an independent physician scientist with the skill and maturity to identify research opportunities and to construct rationale and achievable strategies to address these opportunities. The combination of advanced coursework and mentoring should make this possible. Dr. Lawrence B. Schwartz will serve as mentor. Dr. Zhao recently joined the VCU as an Assistant Professor of Pediatrics beginning July, 2003. Research space has been provided within the Department of Pediatrics along with salary support and protected time.
Human mast cells are effector cells of acquired and probably innate immunity. They are abundant around blood vessels and in cutaneous, gastrointestinal and pulmonary tissues. The ability to obtain human skin-derived mast cells of high purity that proliferate in culture and retain the functional phenotype of the original mast cells provides a critical tool for research on such ceils. The current proposal will examine relationships between these mast cells and cytokines, and the role of such mast cells in the pathogenesis of chronic urticaria. Aim 1 will characterize the cytokines and lipid mediators produced by human skin-derived mast cells activated through FcepsilonRI. Because preliminary results indicate many of the cytokines are degraded during or shortly after their release, presumably by co-released mast cell proteases, conditions will be developed to prevent their degradation and thereby appreciate the full extent of their production. Aim 2 will examine the ability of cytokines to regulate cytokine production and prostaglandin and leukotriene generation by mast cells activated through IgE and IgG receptors. Aim 3 will characterize the ability of sera from patients with chronic urticaria to label the surface of and to activate or prime human skin-derived mast cells. Understanding these functional attributes of human mast cells will provide insights into the pathogenesis of allergic disease and may reveal new therapeutic targets.
描述(由申请人提供):赵博士的长期目标是发展成为一名独立的内科科学家,具备识别研究机会的技能和成熟度,并构建基本原理和可实现的策略来应对这些机会。高级课程和指导的结合应该使这成为可能。Lawrence B. Schwartz博士将担任导师。赵博士最近于2003年7月加入VCU,担任儿科助理教授。在儿科内提供研究空间以及工资支持和保护时间。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Wei Zhao其他文献
Wei Zhao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Wei Zhao', 18)}}的其他基金
Potential Application of Boldine in Alleviating SCI-induced Neuropathic Pain
Boldine 在减轻 SCI 引起的神经病理性疼痛中的潜在应用
- 批准号:
10120253 - 财政年份:2020
- 资助金额:
$ 12.77万 - 项目类别:
Potential Application of Boldine in Alleviating SCI-induced Neuropathic Pain
Boldine 在减轻 SCI 引起的神经病理性疼痛中的潜在应用
- 批准号:
10596059 - 财政年份:2020
- 资助金额:
$ 12.77万 - 项目类别:
Potential Application of Boldine in Alleviating SCI-induced Neuropathic Pain
Boldine 在减轻 SCI 引起的神经病理性疼痛中的潜在应用
- 批准号:
10246188 - 财政年份:2020
- 资助金额:
$ 12.77万 - 项目类别:
Back-irradiated flat panel imager with avalanche gain
具有雪崩增益的背照式平板成像仪
- 批准号:
10094215 - 财政年份:2018
- 资助金额:
$ 12.77万 - 项目类别:
A university-industry partnership for improving the imaging performance of digita
大学与工业界的合作伙伴关系,旨在提高数字成像性能
- 批准号:
8204976 - 财政年份:2010
- 资助金额:
$ 12.77万 - 项目类别:
A university-industry partnership for improving the imaging performance of digita
大学与工业界的合作伙伴关系,旨在提高数字成像性能
- 批准号:
8410039 - 财政年份:2010
- 资助金额:
$ 12.77万 - 项目类别:
A university-industry partnership for improving the imaging performance of digita
大学与工业界的合作伙伴关系,旨在提高数字成像性能
- 批准号:
8038397 - 财政年份:2010
- 资助金额:
$ 12.77万 - 项目类别:
相似国自然基金
KCTD10对2型免疫反应(Th2)的调控研究
- 批准号:2020JJ4441
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
乙烯合酶ACS家族的AEF蛋白调节拟南芥开花时间的机制研究
- 批准号:31970735
- 批准年份:2019
- 资助金额:58.0 万元
- 项目类别:面上项目
USP13调控IL-18诱导的NF-κB活化的分子机制研究
- 批准号:31900556
- 批准年份:2019
- 资助金额:26.0 万元
- 项目类别:青年科学基金项目
let-7通过SOCS1调控巨噬细胞极化及其在前列腺癌进展中的作用
- 批准号:81560465
- 批准年份:2015
- 资助金额:38.0 万元
- 项目类别:地区科学基金项目
纳米微粒载NF-κB圈套基因对神经发育缺陷大鼠模型的干预研究
- 批准号:30870892
- 批准年份:2008
- 资助金额:8.0 万元
- 项目类别:面上项目
相似海外基金
Longitudinal Modeling of Pro-Inflammatory Cytokines, Hazardous Alcohol Use, and Cerebral Metabolites as Predictors of Neurocognitive Change in People with HIV
促炎细胞因子、有害酒精使用和脑代谢物的纵向建模作为 HIV 感染者神经认知变化的预测因子
- 批准号:
10838849 - 财政年份:2024
- 资助金额:
$ 12.77万 - 项目类别:
Role of Frizzled 5 in NK cell development and antiviral host immunity
Frizzled 5 在 NK 细胞发育和抗病毒宿主免疫中的作用
- 批准号:
10748776 - 财政年份:2024
- 资助金额:
$ 12.77万 - 项目类别:
Strategies for next-generation flavivirus vaccine development
下一代黄病毒疫苗开发策略
- 批准号:
10751480 - 财政年份:2024
- 资助金额:
$ 12.77万 - 项目类别:
Development of platform for non-invasive, rapid, and simple analysis of cytokine secretion from single cells
开发非侵入、快速、简单分析单细胞细胞因子分泌的平台
- 批准号:
23H01824 - 财政年份:2023
- 资助金额:
$ 12.77万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Therapeutic approach to confer an anti-tumorigenic role of IL-6 to the pro-tumorigenic cytokine in effector T cells
赋予效应T细胞中促肿瘤细胞因子IL-6抗肿瘤作用的治疗方法
- 批准号:
23K06723 - 财政年份:2023
- 资助金额:
$ 12.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Diversity of haematopoietic cytokine receptor activation exploring with marine probes
用海洋探针探索造血细胞因子受体激活的多样性
- 批准号:
23K14019 - 财政年份:2023
- 资助金额:
$ 12.77万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Bio-Responsive and Immune Protein-Based Therapies for Inhibition of Proteolytic Enzymes in Dental Tissues
用于抑制牙齿组织中蛋白水解酶的基于生物响应和免疫蛋白的疗法
- 批准号:
10555093 - 财政年份:2023
- 资助金额:
$ 12.77万 - 项目类别:
Maternal immune activation remodeling of offspring glycosaminoglycan sulfation patterns during neurodevelopment
神经发育过程中后代糖胺聚糖硫酸化模式的母体免疫激活重塑
- 批准号:
10508305 - 财政年份:2023
- 资助金额:
$ 12.77万 - 项目类别:
Engineering T cells to overcome inhibitory receptor signals that limit the efficacy of adoptive cell therapy against ovarian cancer
改造 T 细胞以克服抑制性受体信号,这些信号限制了过继性细胞疗法对卵巢癌的疗效
- 批准号:
10526155 - 财政年份:2023
- 资助金额:
$ 12.77万 - 项目类别: